TOKYO - Fujifilm Holdings Corp. said Wednesday it will seek regulatory approval as early as October for using its antivirus drug Avigan to treat patients infected with the novel coronavirus as clinical tests have shown efficacy in easing symptoms.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
